13
Views
59
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of Surviving Fraction at 2 Gy as a Potential Prognostic Factor for the Radiotherapy of Carcinoma of the Cervix

, &
Pages 761-765 | Published online: 03 Jul 2009

References

  • Aapro M.S. Growth of solid tumour cells in clonogenic assays: a prognostic factor?. International Journal of Cancer Clinical Oncology 1985; 21: 397–400
  • Courtenay V.D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. British Journal of Cancer 1978; 37: 261–268
  • Davidson S.E., Symonds R.P., Lamont D., Watson E.R. Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma when treated by radiotherapy?. Gynaecology and Oncology 1989; 33: 23–26
  • Deacon J., Peckham M.J., Steel G.G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiotherapy and Oncology 1984; 2: 317–323
  • Fertil B., Malaise E.P. Inherent cellular radiosensitivity as a basic concept for human tumour radiotherapy. International Journal of Radiation Oncology, Biology and Physics 1981; 7: 621–629
  • Fertil B., Malaise E.P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumours: analysis of 101 published survival curves. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 1699–1707
  • Johns M.I., Mills S.E. A possible prognostic indicator in squamous cell carcinoma of the head and neck. Cancer 1983; 52: 1401–1404
  • Kelland L.R., Steel G.G. Differences in radiation response among human cervix carcinoma cell lines. Radiotherapy Oncology 1988; 13: 225–232
  • West C.M.L., Sutherland R.M. A radiobiological comparison of human tumour soft agar clonogenic assays. International Journal of Cancer 1986; 37: 897–903

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.